BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10086727)

  • 1. Identification of a novel molecular partner of the E2A gene in childhood leukemia.
    Brambillasca F; Mosna G; Colombo M; Rivolta A; Caslini C; Minuzzo M; Giudici G; Mizzi L; Biondi A; Privitera E
    Leukemia; 1999 Mar; 13(3):369-75. PubMed ID: 10086727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
    Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
    Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.
    Brambillasca F; Mosna G; Ballabio E; Biondi A; Boulukos KE; Privitera E
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1250-7. PubMed ID: 11700047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene.
    Yoshinari M; Imaizumi M; Eguchi M; Ogasawara M; Saito T; Suzuki H; Koizumi Y; Cui Y; Sato A; Saisho T; Ichinohasama R; Matsubara Y; Kamada N; Iinuma K
    Cancer Genet Cytogenet; 1998 Mar; 101(2):95-102. PubMed ID: 9494609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of E2A translocations in leukemias via fluorescence in situ hybridization.
    Boomer T; Varella-Garcia M; McGavran L; Meltesen L; Olsen AS; Hunger SP
    Leukemia; 2001 Jan; 15(1):95-102. PubMed ID: 11243406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
    Van Dijk MA; Voorhoeve PM; Murre C
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
    Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
    Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL).
    Privitera E; Luciano A; Ronchetti D; Aricò M; Santostasi T; Basso G; Biondi A
    Leukemia; 1994 Apr; 8(4):554-9. PubMed ID: 8152250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP; Ohyashiki K; Toyama K; Cleary ML
    Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
    Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
    J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
    Maloney KW; McGavran L; Odom LF; Hunger SP
    Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2A basic helix-loop-helix transcription factors in human leukemia.
    LeBrun DP
    Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
    Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
    Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S; Kato K; Horibe K
    Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
    Kamps MP; Look AT; Baltimore D
    Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor.
    Nourse J; Mellentin JD; Galili N; Wilkinson J; Stanbridge E; Smith SD; Cleary ML
    Cell; 1990 Feb; 60(4):535-45. PubMed ID: 1967982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [E2A gene in t(1;19)-ALL].
    Hayashi Y
    Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.